TickerSpark Feed

UTHR coverage

Every article, report, and earnings note where UTHR appears.

The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Creates a free TickerSpark account — newsletter included.

Daily market recap + weekly preview. One-click unsubscribe in every email.

Should You Buy the Vicore Pharma Holding AB IPO? Here's the Setup
IPOVCRE

Should You Buy the Vicore Pharma Holding AB IPO? Here's the Setup

Vicore Pharma Holding AB American Depositary Shares are expected to list on NASDAQ on 2026-07-02, with the price range not disclosed yet. This is a U.S. dual listing, not a traditional cash-raising IPO, so the main question is whether the story around buloxibutid is strong enough to attract U.S. investors. The bull case is a first-in-class IPF drug in a large unmet market; the bear case is a clinical-stage company still years from commercialization.

Jul 2, 20265 MIN
On-Demand Research

Want a deeper dive on UTHR?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate UTHR Report